Go Pro

Insider Selling: Adient (NYSE:ADNT) Director Sells $150,977.75 in Stock

Adient logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Adient director Peter Carlin sold 7,843 shares for approximately $150,978 at an average price of $19.25, reducing his position by 16.8% to 38,835 shares.
  • Adient shares recently traded at $19.97, near the stock’s 50-day moving average and below its 1-year high of $27.32. The company’s latest quarterly revenue rose 4.3% year over year to $3.93 billion, but earnings per share missed estimates.
  • Analyst sentiment is mixed, with six Buy, three Hold, and three Sell ratings and an average price target of $26.60. Institutional investors own 92.44% of Adient’s outstanding shares.
  • Five stocks we like better than Adient.

Adient (NYSE:ADNT - Get Free Report) Director Peter Carlin sold 7,843 shares of the company's stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $19.25, for a total value of $150,977.75. Following the sale, the director owned 38,835 shares in the company, valued at $747,573.75. The trade was a 16.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Adient Stock Up 2.0%

Shares of NYSE ADNT traded up $0.40 during trading hours on Friday, hitting $19.97. The company had a trading volume of 619,079 shares, compared to its average volume of 1,016,794. The stock has a market capitalization of $1.54 billion, a P/E ratio of 33.28, a price-to-earnings-growth ratio of 0.39 and a beta of 1.52. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. Adient has a 1-year low of $17.68 and a 1-year high of $27.32. The firm's 50 day moving average is $19.65 and its 200-day moving average is $21.00.

Adient (NYSE:ADNT - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.08). Adient had a net margin of 0.32% and a return on equity of 7.32%. The firm had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same period in the prior year, the business posted $0.45 earnings per share. Adient's quarterly revenue was up 4.3% compared to the same quarter last year. On average, analysts expect that Adient will post 2.02 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Adient

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Adient by 4.7% in the 4th quarter. Vanguard Group Inc. now owns 4,684,882 shares of the company's stock valued at $89,809,000 after purchasing an additional 208,938 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Adient by 5.1% during the first quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company's stock worth $88,614,000 after buying an additional 211,843 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Adient by 17.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company's stock worth $46,349,000 after purchasing an additional 336,306 shares in the last quarter. UBS Group AG boosted its holdings in Adient by 12.9% in the 4th quarter. UBS Group AG now owns 1,848,690 shares of the company's stock valued at $35,439,000 after purchasing an additional 210,758 shares during the period. Finally, California State Teachers Retirement System grew its position in shares of Adient by 1,689.9% during the 2nd quarter. California State Teachers Retirement System now owns 1,699,029 shares of the company's stock worth $31,228,000 after purchasing an additional 1,604,107 shares in the last quarter. Institutional investors and hedge funds own 92.44% of the company's stock.

Analyst Ratings Changes

ADNT has been the topic of several recent analyst reports. Stifel Nicolaus lowered their price objective on shares of Adient from $28.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, July 20th. Morgan Stanley cut their target price on shares of Adient from $22.00 to $21.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 18th. Citigroup reduced their price target on Adient from $33.00 to $29.00 and set a "buy" rating for the company in a report on Tuesday, August 11th. Wells Fargo & Company boosted their price target on Adient from $28.00 to $32.00 and gave the stock an "overweight" rating in a research report on Thursday, June 25th. Finally, BNP Paribas Exane upgraded Adient from a "neutral" rating to an "outperform" rating and set a $26.00 price objective on the stock in a research note on Thursday, July 30th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $26.60.

View Our Latest Stock Report on ADNT

Adient Company Profile

(Get Free Report)

Adient plc NYSE: ADNT is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient's product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Adient Right Now?

Before you consider Adient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.

While Adient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines